|
|
1900 Charleston Road PO BOX 7210 Mountain View, CA 94039-7210 USA phone:(650) 564-5000 fax:(650) 564-7070
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.alza.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Drug delivery solutions using an array of technology platforms.
|
 |
| Management |
| Michael R. Jackson:President;
Erik Wiberg:VP, Business Development Director;
Ellen Rose: Corporate Communications
|
| |
|
|
| |
|
| Keywords |
| drugs, delivery, oral, transdermal, implantable, liposomal |
|
|
|
| Description |
|
ALZA , a subsidiary of Johnson and Johnson, is a provider of drug delivery solutions with a broad array of technology platforms, including oral, transdermal, implantable and liposomal technologies.
|
 |
| Products / Services |
|
 |
| Technology / Differentiation |
| Alza transformed the standard pharmaceutical tablet into an advanced drug delivery system with its OROS osmotic technology that is used in more than a dozen products marketed around the world. ALZA has also introduced the concept of controlled transdermal delivery through seven different patches and the company's STEALTH liposomal technology is the basis for the anticancer agent Doxil (doxorubicin HCl liposome injection).
|
 |
| Market / Customers |
|
 |
| Competitors / Substitutes / Alternatives |
|
 |
| Strategy |
|
 |
| Funding |
| |
 |
| Status |
| |
 |
|
|
| |
|
|
|
|
|
|